BOOK
Metabolic and Bariatric Surgery, An Issue of Surgical Clinics of North America, E-Book
(2016)
Additional Information
Book Details
Abstract
This issue of Surgical Clinics of North America, guest edited by Dr. Adrian Dan, is devoted to Metabolic and Bariatric Surgery. He has assembled expert authors to review the following topics: A Historical Perspective of Metabolic and Bariatric Surgery; The Socio-economic Impact of Morbid Obesity and Factors Affecting Access to Obesity Surgery; Laparoscopic Roux-en-Y Gastric Bypass–Surgical Technique and Peri-operative Care; Revisional Metabolic and Bariatric Surgery; Novel Endoscopic and Surgical Techniques for treatment of Morbid Obesity –A Glimpse into the Future; Management and Prevention of Surgical and Nutritional Complications After Bariatric Surgery; Resolution of Comorbitidies and Impact on Longevity Following Bariatric and Metabolic Surgery; The Effects of Metabolic Surgery upon Fatty Liver Disease and Non-Alcoholic Steatohepatitis; Patient Selection and Surgical Management of High Risk Patients with Morbid Obesity; Laparoscopic Sleeve Gastrectomy–Surgical Technique and Peri-operative Care; Rise and Fall of the LAGB as a Bariatric Procedure; Plastic Surgery and Body Contouring Following Weight Loss Surgery; Biliopancreatic Diversion with Duodenal Switch–Surgical Technique and Periopertive Care; Morbid Obesity, Type 2 Diabetes and the Metabolic Syndrome–Pathophysiologic Relationships and Guidelines for Surgical Intervention; Patient Safety and Quality Improvement Initiatives in Contemporary Metabolic and Bariatric Surgical Practice; Type II Diabetes Mellitus – A Surgical Disease, and more!
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | Cover | ||
| Metabolic and Bariatric Surgery\r | i | ||
| Copyright\r | ii | ||
| Contributors | iii | ||
| CONSULTING EDITOR | iii | ||
| EDITOR | iii | ||
| AUTHORS | iii | ||
| Contents | vii | ||
| Foreword\r | vii | ||
| Preface: Obesity—The Epidemic Crisis of Our Time\r | vii | ||
| A History of Bariatric Surgery: The Maturation of a Medical Discipline\r | vii | ||
| The Socioeconomic Impact of Morbid Obesity and Factors Affecting Access to Obesity Surgery\r | vii | ||
| Obesity, Type 2 Diabetes, and the Metabolic Syndrome: Pathophysiologic\rRelationships and Guidelines for Surgical Intervention\r | vii | ||
| The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis\r | viii | ||
| Resolution of Comorbidities and Impact on Longevity Following Bariatric and Metabolic Surgery\r | viii | ||
| Patient Safety and Quality Improvement Initiatives in Contemporary Metabolic and Bariatric Surgical Practice\r | viii | ||
| Patient Selection and Surgical Management of High-Risk Patients with Morbid Obesity\r | viii | ||
| Laparoscopic Sleeve Gastrectomy: Surgical Technique and Perioperative Care\r | ix | ||
| Laparoscopic Roux-en-Y Gastric Bypass: Surgical Technique and Perioperative Care\r | ix | ||
| Update on Treatment of Morbid Obesity with Adjustable Gastric Banding\r | ix | ||
| Biliopancreatic Diversion with Duodenal Switch: Surgical Technique and Perioperative Care\r | ix | ||
| Revisional Bariatric Surgery\r | x | ||
| Management and Prevention of Surgical and Nutritional Complications After Bariatric Surgery\r | x | ||
| Novel Endoscopic and Surgical Techniques for Treatment of Morbid Obesity: A Glimpse into the Future\r | x | ||
| Body Contouring Surgery in the Massive Weight Loss Patient\r | x | ||
| SURGICAL CLINICS\rOF NORTH AMERICA\r | xii | ||
| FORTHCOMING ISSUES | xii | ||
| October 2016 | xii | ||
| December 2016 | xii | ||
| February 2017 | xii | ||
| RECENT ISSUES | xii | ||
| June 2016 | xii | ||
| April 2016 | xii | ||
| February 2016 | xii | ||
| December 2015 | xii | ||
| Foreword | xiii | ||
| Preface: Obesity—The Epidemic Crisis of Our Time\r | xv | ||
| A History of Bariatric Surgery | 655 | ||
| Key points | 655 | ||
| RECOGNITION | 655 | ||
| DEVELOPMENT OF PROCEDURES | 656 | ||
| Malabsorptive Procedures: Intestinal Bypass | 656 | ||
| Mixed Malabsorptive and Restrictive Procedures | 658 | ||
| Gastric bypass | 658 | ||
| Biliopancreatic diversion and biliopancreatic diversion with duodenal switch | 659 | ||
| Restrictive Procedures | 660 | ||
| Vertical banded gastroplasty | 660 | ||
| Adjustable gastric bands | 661 | ||
| Sleeve gastrectomy | 662 | ||
| Gastric balloon | 662 | ||
| MEASUREMENT OF OUTCOMES | 663 | ||
| A FOCUS ON SAFETY | 663 | ||
| SUMMARY | 664 | ||
| REFERENCES | 664 | ||
| The Socioeconomic Impact of Morbid Obesity and Factors Affecting Access to Obesity Surgery | 669 | ||
| Key points | 669 | ||
| PREVALENCE OF OBESITY | 669 | ||
| ECONOMIC IMPACT OF OBESITY | 672 | ||
| Health Care Costs of Obesity | 672 | ||
| Work-Related Costs of Obesity | 674 | ||
| ECONOMIC IMPACT OF BARIATRIC AND METABOLIC SURGERY | 675 | ||
| FACTORS EFFECTING ACCESS TO BARIATRIC AND METABOLIC SURGERY | 676 | ||
| SUMMARY | 677 | ||
| REFERENCES | 678 | ||
| Obesity, Type 2 Diabetes, and the Metabolic Syndrome | 681 | ||
| Key points | 681 | ||
| INTRODUCTION | 682 | ||
| Obesity and the Adipose Tissue | 682 | ||
| Metabolic Syndrome: Definitions and Pathophysiologic Aspects | 683 | ||
| LINKING OBESITY TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME: PATHOPHYSIOLOGIC EVIDENCE | 685 | ||
| Insulin Resistance | 685 | ||
| Pancreatic β-Cell Dysfunction and Defective Insulin Secretion | 685 | ||
| The Adipose Tissue in Metabolic Diseases | 686 | ||
| Factors with deleterious effects on metabolism | 686 | ||
| Free fatty acids | 686 | ||
| Proinflammatory adipocytokines | 687 | ||
| Protective adipocyte-derived factors | 687 | ||
| Body fat distribution | 687 | ||
| Tissular and Systemic Inflammation | 687 | ||
| Obstructive Sleep Apnea Syndrome | 688 | ||
| Sympathetic Nervous System Overdrive | 688 | ||
| THE GUT AS A BIOLOGICALLY RATIONAL TARGET FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES | 688 | ||
| Mechanisms Linking the Gut to Cardiometabolic Diseases | 688 | ||
| Gut microbiota | 688 | ||
| Alterations of intestinal permeability and metabolic endotoxemia | 689 | ||
| Gut Adaptation to Bariatric/Metabolic Surgery | 689 | ||
| Gastrointestinal hormones | 689 | ||
| Bile acids | 690 | ||
| Gut microbiota | 690 | ||
| Intestinal remodeling | 690 | ||
| Intestinal nutrient sensing | 691 | ||
| Changes in food preference: the gut-brain axis | 691 | ||
| GUIDELINES FOR SURGICAL TREATMENT OF OBESITY AND DIABETES | 691 | ||
| SUMMARY | 693 | ||
| REFERENCES | 693 | ||
| The Effects of Metabolic Surgery on Fatty Liver Disease and Nonalcoholic Steatohepatitis | 703 | ||
| Key points | 703 | ||
| INTRODUCTION | 703 | ||
| PATHOPHYSIOLOGY | 705 | ||
| Insulin Resistance | 705 | ||
| Inflammatory State of Metabolic Syndrome | 706 | ||
| Genetic Predisposition | 706 | ||
| CLINICAL PRESENTATION AND DIAGNOSIS | 707 | ||
| MEDICAL MANAGEMENT OF FATTY LIVER DISEASE | 708 | ||
| SURGICAL MANAGEMENT OF FATTY LIVER DISEASE | 709 | ||
| SUMMARY | 711 | ||
| REFERENCES | 712 | ||
| Resolution of Comorbidities and Impact on Longevity Following Bariatric and Metabolic Surgery | 717 | ||
| Key points | 717 | ||
| IMPACT OF OBESITY ON MORTALITY | 717 | ||
| EFFECT OF BARIATRIC AND METABOLIC SURGERY ON ALL-CAUSE MORTALITY | 719 | ||
| EFFECT OF BARIATRIC AND METABOLIC SURGERY ON WEIGHT-RELATED COMORBIDITIES AND DISEASE-SPECIFIC MORTALITY | 721 | ||
| Cardiovascular Disease | 721 | ||
| Diabetes | 725 | ||
| Cancer | 726 | ||
| SUMMARY | 729 | ||
| REFERENCES | 730 | ||
| Patient Safety and Quality Improvement Initiatives in Contemporary Metabolic and Bariatric Surgical Practice | 733 | ||
| Key points | 733 | ||
| INTRODUCTION | 733 | ||
| PATIENT SAFETY AND QUALITY IMPROVEMENT IN BARIATRIC SURGERY | 734 | ||
| ACCREDITATION | 734 | ||
| Impact of Accreditation | 735 | ||
| PROCESSES AND QUALITY IMPROVEMENT | 737 | ||
| Deep Venous Thromboembolism Prevention | 737 | ||
| Ulcer Prophylaxis | 737 | ||
| Gallstone Prophylaxis | 738 | ||
| PROCESS IMPROVEMENT: DECREASING READMISSIONS THROUGH OPPORTUNITIES PROVIDED | 738 | ||
| REFERENCES | 739 | ||
| Patient Selection and Surgical Management of High-Risk Patients with Morbid Obesity | 743 | ||
| Key points | 743 | ||
| INTRODUCTION | 743 | ||
| IDENTIFICATION OF HIGH-RISK FACTORS | 744 | ||
| Age | 744 | ||
| Gender | 745 | ||
| Body Mass Index | 745 | ||
| Deep Vein Thrombosis | 746 | ||
| Cardiovascular Risk | 746 | ||
| Obstructive Sleep Apnea | 746 | ||
| Diabetes Mellitus | 747 | ||
| Functional Status | 747 | ||
| Surgical Factors | 747 | ||
| Estimating the Risk | 748 | ||
| SPECIAL HIGH-RISK POPULATIONS | 750 | ||
| Patients with Severe End-Organ Disease | 750 | ||
| Cardiac Failure | 750 | ||
| Lung Failure | 751 | ||
| Liver Failure | 751 | ||
| Cirrhosis | 753 | ||
| Kidney Failure | 753 | ||
| Pancreas | 755 | ||
| Immunosuppressed Patients | 755 | ||
| Intraoperative Conduct | 755 | ||
| Postoperative Management | 756 | ||
| REFERENCES | 756 | ||
| Laparoscopic Sleeve Gastrectomy | 763 | ||
| Key points | 763 | ||
| INTRODUCTION | 763 | ||
| PREOPERATIVE PLANNING | 764 | ||
| SURGICAL TECHNIQUE | 765 | ||
| IMMEDIATE POSTOPERATIVE CARE | 767 | ||
| LONG-TERM OUTCOMES | 768 | ||
| SUMMARY | 769 | ||
| SUPPLEMENTARY DATA | 769 | ||
| REFERENCES | 769 | ||
| Laparoscopic Roux-en-Y Gastric Bypass | 773 | ||
| Key points | 773 | ||
| INTRODUCTION | 773 | ||
| SURGICAL TECHNIQUE | 774 | ||
| Preoperative Planning | 774 | ||
| Preparation and Patient Positioning | 775 | ||
| Surgical Approach | 775 | ||
| SURGICAL PROCEDURE | 775 | ||
| Trocar Placement | 775 | ||
| Creation of the Gastric Pouch | 776 | ||
| Construction of the Roux and Biliopancreatic Limbs | 776 | ||
| Creation of the Jejunojenostomy | 777 | ||
| Gastrojejunal Anastomosis | 777 | ||
| Gastrojejunal Anastomosis: Transoral Circular Stapler Technique | 780 | ||
| Gastrojejunal Anastomosis: Linear Stapler Technique | 781 | ||
| Gastrojejunal Anastomosis: Hand Sewn Technique | 782 | ||
| COMPLICATIONS | 782 | ||
| IMMEDIATE POSTOPERATIVE CARE | 784 | ||
| LONG-TERM CARE AND FOLLOW-UP | 786 | ||
| CLINICAL RESULTS IN THE LITERATURE | 786 | ||
| SUMMARY | 787 | ||
| SUPPLEMENTARY DATA | 787 | ||
| REFERENCES | 787 | ||
| Update on Treatment of Morbid Obesity with Adjustable Gastric Banding | 795 | ||
| Key points | 795 | ||
| INTRODUCTION | 795 | ||
| HISTORY | 796 | ||
| Nonadjustable Bands | 796 | ||
| Adjustable Bands | 797 | ||
| Laparoscopy for Adjustable Gastric Bands | 797 | ||
| EVOLUTION AND TECHNICAL ADVANCEMENT OF THE LAPAROSCOPIC ADJUSTABLE GASTRIC BAND | 798 | ||
| Adoption of Laparoscopy | 798 | ||
| The Pars Flaccida Technique | 799 | ||
| Design Changes of the Laparoscopic Adjustable Gastric Band | 800 | ||
| Increased Popularity of Laparoscopic Adjustable Gastric Band | 800 | ||
| COMPLICATIONS | 801 | ||
| Acute Slippage | 801 | ||
| Chronic Pouch Dilatation | 802 | ||
| Esophageal Dilatation | 803 | ||
| Band Erosion | 803 | ||
| Port-related Complications | 805 | ||
| Gastroesophageal Reflux Disease | 805 | ||
| Gastric Perforation | 806 | ||
| Failure of Weight Loss | 806 | ||
| RESULTS | 806 | ||
| Longevity of Laparoscopic Adjustable Gastric Band | 807 | ||
| Concerning Results | 807 | ||
| Laparoscopic Adjustable Gastric Banding in Adolescents | 808 | ||
| Laparoscopic Adjustable Gastric Banding for Lower Body Mass Indices | 808 | ||
| FUTURE OF LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING | 808 | ||
| SUMMARY | 809 | ||
| REFERENCES | 810 | ||
| Biliopancreatic Diversion with Duodenal Switch | 815 | ||
| Key points | 815 | ||
| INTRODUCTION | 815 | ||
| SURGICAL TECHNIQUE | 816 | ||
| Preoperative Planning | 816 | ||
| Preoperative Work-up | 817 | ||
| Preparation and Patient Positioning | 817 | ||
| Positioning | 818 | ||
| Surgical Approach | 818 | ||
| Step 1: gastric mobilization | 818 | ||
| Step 2: duodenal dissection | 819 | ||
| Inferior approach | 819 | ||
| Posterior approach | 819 | ||
| Step 3: sleeve gastrectomy | 820 | ||
| Step 4: small bowel transection | 820 | ||
| Step 5: duodenoileal anastomosis | 820 | ||
| Step 5: ileoileal anastomosis | 821 | ||
| Postoperative Period | 822 | ||
| SUMMARY OF CLINICAL OUTCOMES | 823 | ||
| Long-Term Outcomes After Biliopancreatic Diversion with Duodenal Switch | 824 | ||
| Perioperative Morbidity and Mortality | 824 | ||
| SUMMARY | 825 | ||
| SUPPLEMENTARY DATA | 825 | ||
| REFERENCES | 825 | ||
| Revisional Bariatric Surgery | 827 | ||
| Key points | 827 | ||
| ADJUSTABLE GASTRIC BAND/LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING | 827 | ||
| History | 827 | ||
| Brief description of the surgical procedure | 828 | ||
| Indications for Revision | 828 | ||
| Inadequate weight loss and secondary weight recividism | 828 | ||
| Hardware problems | 828 | ||
| Motility problems | 829 | ||
| Conversion Strategies | 829 | ||
| Key principles | 829 | ||
| Adjustable gastric band/laparoscopic adjustable gastric banding removal | 830 | ||
| Adjustable gastric band/laparoscopic adjustable gastric banding replacement/refixation | 830 | ||
| Adjustable gastric band/laparoscopic adjustable gastric banding to Roux-en-Y gastric bypass | 830 | ||
| Adjustable gastric band/laparoscopic adjustable gastric banding to laparoscopic sleeve gastrectomy | 830 | ||
| Adjustable gastric band/laparoscopic adjustable gastric banding to biliopancreatic diversion with duodenal switch | 831 | ||
| LEGACY PROCEDURE | 831 | ||
| The Nonadjustable Gastric Band | 831 | ||
| Management and Prevention of Surgical and Nutritional Complications After Bariatric Surgery | 843 | ||
| Key points | 843 | ||
| PERIOPERATIVE COMPLICATIONS | 844 | ||
| INTRAOPERATIVE SURGICAL COMPLICATIONS | 844 | ||
| Laparoscopic Entry Technique | 844 | ||
| Small Bowel/Hollow Organ Injury | 844 | ||
| Solid Organ Injury | 845 | ||
| Anastomosis Revision | 845 | ||
| Staple Line Bleeding | 846 | ||
| Bleeding from Trocar Site | 846 | ||
| POSTOPERATIVE SURGICAL COMPLICATIONS | 846 | ||
| Bleeding | 846 | ||
| Obstruction | 847 | ||
| Infections | 847 | ||
| NUTRITIONAL COMPLICATIONS | 848 | ||
| Postoperative Diet | 848 | ||
| Nutrient Metabolism | 849 | ||
| Deficiencies (Macronutrients and Micronutrients) | 850 | ||
| Follow-Up of Laboratory Studies for Monitoring | 853 | ||
| SUMMARY | 853 | ||
| REFERENCES | 853 | ||
| Novel Endoscopic and Surgical Techniques for Treatment of Morbid Obesity | 857 | ||
| Key points | 857 | ||
| INTRODUCTION | 857 | ||
| NOVEL PRIMARY ENDOSCOPIC BARIATRIC PROCEDURES | 859 | ||
| Space-occupying Procedures | 859 | ||
| Endoscopic Barrier Therapy | 861 | ||
| Endoscopic Sutured Gastroplasty | 863 | ||
| Endoscopically Placed Aspiration Therapy Device | 863 | ||
| NOVEL PRIMARY LAPAROSCOPIC SURGICAL BARIATRIC PROCEDURES | 865 | ||
| Laparoscopic Single-anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy | 865 | ||
| Laparoscopic Greater Curvature Plication | 866 | ||
| Laparoscopic Gastric Stimulation Therapy for Obesity | 866 | ||
| Revisional Endoscopic Procedures | 868 | ||
| SUMMARY | 871 | ||
| REFERENCES | 871 | ||
| Body Contouring Surgery in the Massive Weight Loss Patient | 875 | ||
| Key points | 875 | ||
| INTRODUCTION | 875 | ||
| CURRENT APPROACH AND PRINCIPLES | 876 | ||
| CLINICAL EXPERIENCE | 880 | ||
| SUMMARY | 883 | ||
| REFERENCES | 883 | ||
| Index | 887 |